NVOS logo

Novo Integrated Sciences (NVOS) Cash From Financing

Annual CFF

$763.90 K
+$1.19 M+278.86%

August 31, 2023

Summary

Performance

1-Year Change

+278.86%

3-Year Change

+381.16%

5-Year Change

+6685.34%

15-Year Change

-75.42%

NVOS Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.82%
NVOS annual cash flow from financing activities is higher than 34.82% of companies in Healthcare sector

High & Low

All-time High

$4.32 M
NVOS annual cash flow from financing activities is currently -82.30% below its historical high of $4.32 million

3-Year Low

-$427.10 K

Earnings dates

Last Annual Earnings Report Date

Aug 31, 2023
NVOS previous annual earnings announcement was published on Aug 31, 2023

Next Annual Earnings Report Date

N/A
NVOS next annual earnings announcement has not yet been scheduled

OtherNVOScash flowmetrics:

Annual CFI

-$49.20 K
NVOS annual cash flow from investing activities is -$49.20 thousand

Annual CFO

-$2.24 M
NVOS annual cash flow from operations is -$2.24 million

Annual FCF

-$2.29 M
NVOS annual free cash flow is -$2.29 million

Annual CAPEX

$49.20 K
NVOS annual capital expenditures is $49.20 thousand

Quarterly CFF

$1.82 M
+$1.82 M+56762.50%

May 31, 2024

Summary

Performance

3-Month Change

+56762.5%

1-Year Change

+101.95%

3-Year Change

+275.98%

5-Year Change

+275.98%

NVOS Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.83%
NVOS quarterly cash flow from financing activities is higher than 69.83% of companies in Healthcare sector

High & Low

All-time High

$9.44 M
NVOS quarterly cash flow from financing activities is currently -80.72% below its historical high of $9.44 million

3-Year Low

-$11.23 M

Earnings dates

Last Quarterly Earnings Report Date

May 31, 2024
NVOS previous earnings announcement was published on May 31, 2024

Next Quarterly Earnings Report Date

N/A
NVOS next earnings announcement has not yet been scheduled

OtherNVOScash flowmetrics:

Quarterly CFI

-$2000.00
NVOS quarterly cash flow from investing activities is -$2000.00

Quarterly CFO

-$658.00 K
NVOS quarterly cash flow from operations is -$658.00 thousand

Quarterly FCF

-$660.00 K
NVOS quarterly free cash flow is -$660.00 thousand

Quarterly CAPEX

$2000.00
NVOS quarterly capital expenditures is $2000.00

TTM CFF

$5.59 M
+$918.60 K+19.68%

May 31, 2024

Summary

Performance

3-Month Change

+19.68%

1-Year Change

+151.1%

3-Year Change

+295.27%

5-Year Change

+295.27%

NVOS TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.9%
NVOS TTM cash flow from financing activities is higher than 44.9% of companies in Healthcare sector

High & Low

All-time High

$15.14 M
NVOS TTM cash flow from financing activities is currently -63.09% below its historical high of $15.14 million

3-Year Low

-$11.87 M

Earnings dates

Last Quarterly Earnings Report Date

May 31, 2024
NVOS previous earnings announcement was published on May 31, 2024

Next Quarterly Earnings Report Date

N/A
NVOS next earnings announcement has not yet been scheduled

OtherNVOScash flowmetrics:

TTM CFI

-$32.40 K
NVOS TTM cash flow from investing activities is -$32.40 thousand

TTM CFO

-$4.75 M
NVOS TTM cash flow from operations is -$4.75 million

TTM FCF

-$4.79 M
NVOS TTM free cash flow is -$4.79 million

TTM CAPEX

$32.40 K
NVOS TTM capital expenditures is $32.40 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NVOS Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+278.9%+102.0%+151.1%
3 y3 years+381.2%+276.0%+295.3%
5 y5 years+6685.3%+276.0%+295.3%

NVOS Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-82.3%+278.9%-80.7%+116.2%-63.1%+147.1%
5 y5-year-82.3%+278.9%-80.7%+116.2%-63.1%+147.1%
alltimeall time-82.3%+278.9%-80.7%+116.2%-63.1%+147.1%

Novo Integrated Sciences Cash From Financing History

DateAnnualQuarterlyTTM
May 2024
-
$1.82 M(>+9900.0%)
$5.59 M(+19.7%)
Feb 2024
-
$3200.00(-99.9%)
$4.67 M(-8.4%)
Nov 2023
-
$3.30 M(+605.1%)
$5.09 M(+566.9%)
Aug 2023
$763.90 K(-278.9%)
$467.50 K(-48.1%)
$763.80 K(-107.0%)
May 2023
-
$901.00 K(+109.9%)
-$10.93 M(-7.9%)
Feb 2023
-
$429.30 K(-141.5%)
-$11.87 M(+315.0%)
Nov 2022
-
-$1.03 M(-90.8%)
-$2.86 M(+569.8%)
Aug 2022
-$427.10 K(-109.9%)
-$11.23 M(>+9900.0%)
-$427.10 K(-105.4%)
May 2022
-
-$37.20 K(-100.4%)
$7.96 M(-47.4%)
Feb 2022
-
$9.44 M(+574.4%)
$15.14 M(+166.8%)
Nov 2021
-
$1.40 M(-149.2%)
$5.67 M(+31.4%)
Aug 2021
$4.32 M(-1688.8%)
-$2.85 M(-139.8%)
$4.32 M(-36.9%)
May 2021
-
$7.14 M(<-9900.0%)
$6.85 M(-3164.7%)
Feb 2021
-
-$22.30 K(-151.1%)
-$223.40 K(-13.5%)
Nov 2020
-
$43.60 K(-113.8%)
-$258.20 K(-5.0%)
Aug 2020
-$271.70 K(-108.8%)
-$315.60 K(-545.1%)
-$271.70 K(-765.9%)
May 2020
-
$70.90 K(-224.2%)
$40.80 K(-93.3%)
Feb 2020
-
-$57.10 K(-289.7%)
$609.20 K(-76.6%)
Nov 2019
-
$30.10 K(-1071.0%)
$2.61 M(-15.2%)
Aug 2019
$3.07 M(<-9900.0%)
-$3100.00(-100.5%)
$3.07 M(-0.5%)
May 2019
-
$639.30 K(-67.0%)
$3.09 M(+14.5%)
Feb 2019
-
$1.94 M(+290.1%)
$2.70 M(+302.6%)
Nov 2018
-
$497.40 K(+4225.2%)
$669.70 K(-5873.3%)
Aug 2018
-$11.60 K(-100.4%)
$11.50 K(-95.4%)
-$11.60 K(-49.8%)
May 2018
-
$247.40 K(-385.7%)
-$23.10 K(-91.5%)
Feb 2018
-
-$86.60 K(-52.9%)
-$270.50 K(+60.2%)
Nov 2017
-
-$183.90 K(-1326.0%)
-$168.90 K(-235.1%)
Aug 2017
$3.11 M(+1971.7%)
-
-
Mar 2017
-
$15.00 K(-76.9%)
$125.00 K(-16.7%)
Dec 2016
$150.00 K(-20.2%)
$65.00 K(+333.3%)
$150.00 K(+42.9%)
Sep 2016
-
$15.00 K(-50.0%)
$105.00 K(-25.0%)
Jun 2016
-
$30.00 K(-25.0%)
$140.00 K(-28.2%)
Mar 2016
-
$40.00 K(+100.0%)
$195.00 K(+3.8%)
Dec 2015
$187.90 K(+30.1%)
$20.00 K(-60.0%)
$187.90 K(-8.5%)
Sep 2015
-
$50.00 K(-41.2%)
$205.40 K(+7.0%)
Jun 2015
-
$85.00 K(+158.4%)
$192.00 K(+51.8%)
Mar 2015
-
$32.90 K(-12.3%)
$126.50 K(-12.4%)
Dec 2014
$144.40 K
$37.50 K(+2.5%)
$144.40 K(-3.8%)
Sep 2014
-
$36.60 K(+87.7%)
$150.10 K(-18.6%)
DateAnnualQuarterlyTTM
Jun 2014
-
$19.50 K(-61.6%)
$184.30 K(-19.8%)
Mar 2014
-
$50.80 K(+17.6%)
$229.80 K(-6.8%)
Dec 2013
$246.50 K(-55.8%)
$43.20 K(-39.0%)
$246.50 K(+6.8%)
Sep 2013
-
$70.80 K(+8.9%)
$230.80 K(+1.5%)
Jun 2013
-
$65.00 K(-3.7%)
$227.50 K(-19.6%)
Mar 2013
-
$67.50 K(+145.5%)
$282.90 K(-49.2%)
Dec 2012
$557.30 K(+64.5%)
$27.50 K(-59.3%)
$557.30 K(-3.5%)
Sep 2012
-
$67.50 K(-43.9%)
$577.30 K(+5.6%)
Jun 2012
-
$120.40 K(-64.8%)
$546.60 K(+11.3%)
Mar 2012
-
$341.90 K(+619.8%)
$491.00 K(+44.9%)
Dec 2011
$338.80 K(-71.3%)
$47.50 K(+29.1%)
$338.90 K(+9.3%)
Sep 2011
-
$36.80 K(-43.2%)
$310.00 K(-44.8%)
Jun 2011
-
$64.80 K(-65.9%)
$561.20 K(-20.8%)
Mar 2011
-
$189.80 K(+920.4%)
$708.50 K(-40.0%)
Dec 2010
$1.18 M(-24.0%)
$18.60 K(-93.5%)
$1.18 M(-36.3%)
Sep 2010
-
$288.00 K(+35.8%)
$1.85 M(-9.3%)
Jun 2010
-
$212.10 K(-68.0%)
$2.04 M(+5.7%)
Mar 2010
-
$662.20 K(-4.1%)
$1.93 M(+24.4%)
Dec 2009
$1.55 M(+405.3%)
$690.70 K(+44.6%)
$1.55 M(+76.6%)
Sep 2009
-
$477.70 K(+366.0%)
$880.30 K(+76.6%)
Jun 2009
-
$102.50 K(-63.8%)
$498.40 K(-11.0%)
Mar 2009
-
$283.40 K(+1597.0%)
$560.00 K(+82.0%)
Dec 2008
$307.60 K(-41.3%)
$16.70 K(-82.6%)
$307.70 K(-25.5%)
Sep 2008
-
$95.80 K(-41.6%)
$412.80 K(-11.4%)
Jun 2008
-
$164.10 K(+427.7%)
$466.10 K(+41.2%)
Mar 2008
-
$31.10 K(-74.5%)
$330.00 K(-37.0%)
Dec 2007
$524.10 K(+17.4%)
$121.80 K(-18.3%)
$524.00 K(+15.1%)
Sep 2007
-
$149.10 K(+432.5%)
$455.30 K(+8.0%)
Jun 2007
-
$28.00 K(-87.6%)
$421.70 K(-31.0%)
Mar 2007
-
$225.10 K(+323.9%)
$611.30 K(+36.9%)
Dec 2006
$446.30 K(+225.1%)
$53.10 K(-54.0%)
$446.40 K(+3.2%)
Sep 2006
-
$115.50 K(-46.9%)
$432.60 K(+32.7%)
Jun 2006
-
$217.60 K(+261.5%)
$326.00 K(+87.1%)
Mar 2006
-
$60.20 K(+53.2%)
$174.20 K(+26.9%)
Dec 2005
$137.30 K(+153.3%)
$39.30 K(+341.6%)
$137.30 K(+40.1%)
Sep 2005
-
$8900.00(-86.5%)
$98.00 K(+10.0%)
Jun 2005
-
$65.80 K(+182.4%)
$89.10 K(+282.4%)
Mar 2005
-
$23.30 K
$23.30 K
Dec 2004
$54.20 K
-
-

FAQ

  • What is Novo Integrated Sciences annual cash flow from financing activities?
  • What is the all time high annual CFF for Novo Integrated Sciences?
  • What is Novo Integrated Sciences annual CFF year-on-year change?
  • What is Novo Integrated Sciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Novo Integrated Sciences?
  • What is Novo Integrated Sciences quarterly CFF year-on-year change?
  • What is Novo Integrated Sciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Novo Integrated Sciences?
  • What is Novo Integrated Sciences TTM CFF year-on-year change?

What is Novo Integrated Sciences annual cash flow from financing activities?

The current annual CFF of NVOS is $763.90 K

What is the all time high annual CFF for Novo Integrated Sciences?

Novo Integrated Sciences all-time high annual cash flow from financing activities is $4.32 M

What is Novo Integrated Sciences annual CFF year-on-year change?

Over the past year, NVOS annual cash flow from financing activities has changed by +$1.19 M (+278.86%)

What is Novo Integrated Sciences quarterly cash flow from financing activities?

The current quarterly CFF of NVOS is $1.82 M

What is the all time high quarterly CFF for Novo Integrated Sciences?

Novo Integrated Sciences all-time high quarterly cash flow from financing activities is $9.44 M

What is Novo Integrated Sciences quarterly CFF year-on-year change?

Over the past year, NVOS quarterly cash flow from financing activities has changed by +$918.60 K (+101.95%)

What is Novo Integrated Sciences TTM cash flow from financing activities?

The current TTM CFF of NVOS is $5.59 M

What is the all time high TTM CFF for Novo Integrated Sciences?

Novo Integrated Sciences all-time high TTM cash flow from financing activities is $15.14 M

What is Novo Integrated Sciences TTM CFF year-on-year change?

Over the past year, NVOS TTM cash flow from financing activities has changed by +$16.52 M (+151.10%)